42.31
Crinetics Pharmaceuticals Inc (CRNX) 最新ニュース
Hyperparathyroidism Pipeline 2025: Innovative Clinical Developments by 3+ Global Leaders – DelveInsight | Featuring Shanghai Hengrui Pharmaceutical, Shaanxi Micot Technology, Crinetics Pharmaceuticals - Barchart.com
Crinetics Pharmaceuticals Inc. stock outlook for YEAR2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com
Will Crinetics Pharmaceuticals Inc. benefit from macro trends2025 Risk Factors & Consistent Growth Equity Picks - newser.com
Will Crinetics Pharmaceuticals Inc. stock keep outperforming rivals2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Is it time to cut losses on Crinetics Pharmaceuticals Inc.2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Sector ETF performance correlation with Crinetics Pharmaceuticals Inc.Analyst Upgrade & Short-Term High Return Strategies - newser.com
Published on: 2025-10-15 10:15:16 - newser.com
Using data tools to time your Crinetics Pharmaceuticals Inc. exitRecession Risk & AI Forecast Swing Trade Picks - newser.com
What recovery options are there for Crinetics Pharmaceuticals Inc.Market Performance Summary & Fast Entry High Yield Stock Tips - newser.com
Crinetics Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Why Crinetics Pharmaceuticals (CRNX) Is Up 6.8% After FDA Approval of First Oral Acromegaly Therapy - Sahm
How to use a screener to detect Crinetics Pharmaceuticals Inc. breakouts2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Published on: 2025-10-13 23:24:35 - newser.com
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
What candlestick patterns are forming on Crinetics Pharmaceuticals Inc.2025 Dividend Review & Free Community Consensus Stock Picks - newser.com
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Is it too late to sell Crinetics Pharmaceuticals Inc.Market Trend Summary & Verified Swing Trading Watchlists - newser.com
Crinetics Pharmaceuticals' (CRNX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Will a bounce in Crinetics Pharmaceuticals Inc. offer an exit2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Crinetics stock holds Overweight rating at Piper Sandler after acromegaly drug approval - Investing.com Canada
Crinetics Pharmaceuticals’ SWOT analysis: oral endocrine drug stock poised for growth - Investing.com Nigeria
Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX) - Yahoo Finance
A Look at Crinetics Pharmaceuticals's Valuation Following FDA Approval of PALSONIFY for Acromegaly - Yahoo Finance
Crinetics Pharmaceuticals (CRNX): Assessing Valuation After a 15% Share Price Climb This Month - Sahm
Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Using portfolio simulators with Crinetics Pharmaceuticals Inc. includedWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - newser.com
What MACD and RSI say about Crinetics Pharmaceuticals Inc.Earnings Recap Report & Capital Efficient Trade Techniques - newser.com
Does Crinetics Pharmaceuticals Inc. fit your quant trading model2025 Support & Resistance & High Yield Stock Recommendations - newser.com
Comparing Crinetics Pharmaceuticals Inc. in custom built stock radarsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Crinetics Pharmaceuticals Shares Swing After Data on Paltusotine and Valuation Metrics Scrutinized - Sahm
Insider Selling: Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Sells 5,000 Shares of Stock - MarketBeat
Crinetics Pharmaceuticals Hits Day High with 16.05% Surge in Stock Price - Markets Mojo
大文字化:
|
ボリューム (24 時間):